FBLG vs. BIVI

Last updated Apr 2, 2026

Compare and contrast key facts about FibroBiologics, Inc (FBLG) and BioVie Inc. (BIVI).

Performance

FBLG vs. BIVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in FibroBiologics, Inc (FBLG) and BioVie Inc. (BIVI). The values are adjusted to include any dividend payments, if applicable.

FBLG vs. BIVI - Yearly Performance Comparison

	2026 (YTD)	2025	2024
FBLG FibroBiologics, Inc	-70.43%	-88.76%	-93.13%
BIVI BioVie Inc.	18.97%	-94.20%	-80.77%

Fundamentals

EPS FBLG : -$0.45 BIVI : -$1.88
Total Revenue (TTM) FBLG : $0.00 BIVI : $0.00
Gross Profit (TTM) FBLG : -$231.00K BIVI : -$172.03K
EBITDA (TTM) FBLG : -$17.74M BIVI : -$17.44M

Returns By Period

In the year-to-date period, FBLG achieves a -70.43% return, which is significantly lower than BIVI's 18.97% return.

FBLG

• 1D: 0.76%
• 1M: -84.15%
• YTD: -70.43%
• 6M: -87.29%
• 1Y: -92.27%
• 3Y*: —
• 5Y*: —
• 10Y*: —

BIVI

• 1D: -1.43%
• 1M: 2.99%
• YTD: 18.97%
• 6M: -30.65%
• 1Y: -83.57%
• 3Y*: -88.05%
• 5Y*: -76.36%
• 10Y*: -52.53%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

FBLG vs. BIVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBLG

FBLG Risk / Return Rank: 6
FBLG Sharpe Ratio Rank: 10
FBLG Sortino Ratio Rank: 4
FBLG Omega Ratio Rank: 4
FBLG Calmar Ratio Rank: 3
FBLG Martin Ratio Rank: 9

BIVI

BIVI Risk / Return Rank: 9
BIVI Sharpe Ratio Rank: 9
BIVI Sortino Ratio Rank: 6
BIVI Omega Ratio Rank: 6
BIVI Calmar Ratio Rank: 5
BIVI Martin Ratio Rank: 18

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FBLG vs. BIVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for FibroBiologics, Inc (FBLG) and BioVie Inc. (BIVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FBLG	BIVI	Difference
Sharpe ratio Return per unit of total volatility	-0.72	-0.78	+0.06
Sortino ratio Return per unit of downside risk	-1.70	-1.45	-0.24
Omega ratio Gain probability vs. loss probability	0.78	0.81	-0.03
Calmar ratio Return relative to maximum drawdown	-0.97	-0.94	-0.03
Martin ratio Return relative to average drawdown	-1.46	-1.19	-0.27
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FBLG vs. BIVI - Sharpe Ratio Comparison

The current FBLG Sharpe Ratio is -0.72, which is comparable to the BIVI Sharpe Ratio of -0.78. The chart below compares the historical Sharpe Ratios of FBLG and BIVI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	FBLG	BIVI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.72	-0.78	+0.06
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.58	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.27	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.60	-0.23	-0.37

Correlation

The correlation between FBLG and BIVI is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

FBLG vs. BIVI - Dividend Comparison

Neither FBLG nor BIVI has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

FBLG vs. BIVI - Drawdown Comparison

The maximum FBLG drawdown since its inception was -99.77%, roughly equal to the maximum BIVI drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for FBLG and BIVI.

Drawdown Indicators

	FBLG	BIVI	Difference
Max Drawdown Largest peak-to-trough decline	-99.77%	-99.98%	+0.21%
Max Drawdown (1Y) Largest decline over 1 year	-95.22%	-91.38%	-3.84%
Max Drawdown (5Y) Largest decline over 5 years	—	-99.95%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.98%	—
Current Drawdown Current decline from peak	-99.77%	-99.98%	+0.21%
Average Drawdown Average peak-to-trough decline	-89.43%	-77.66%	-11.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	63.56%	72.26%	-8.70%

Volatility

FBLG vs. BIVI - Volatility Comparison

FibroBiologics, Inc (FBLG) has a higher volatility of 76.72% compared to BioVie Inc. (BIVI) at 26.25%. This indicates that FBLG's price experiences larger fluctuations and is considered to be riskier than BIVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FBLG	BIVI	Difference
Volatility (1M) Calculated over the trailing 1-month period	76.72%	26.25%	+50.47%
Volatility (6M) Calculated over the trailing 6-month period	121.36%	51.57%	+69.79%
Volatility (1Y) Calculated over the trailing 1-year period	127.77%	108.35%	+19.42%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	157.18%	131.61%	+25.57%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	157.18%	197.90%	-40.72%

Financials